Myasthenia gravis (MG) is a chronic autoimmune neuromuscular junction disorder mediated by autoantibodies. Existing diagnostic methods mainly rely on serum antibody detection and electrophysiological testing, which are limited by invasiveness and suboptimal sensitivity and specificity.
Product: Human Tumor protein D52 (TPD52) ELISA Kit
Pub Date：2026-01-09 IF: 2.600
Cancer cachexia is a syndrome characterized by profound weight loss, muscle wasting, and metabolic disturbance in cancer patients. Cancer-associated cachexia represents significant biological and clinical challenges that profoundly affect human health. Approximately 20 % of cancer patients succumb directly to cachexia-related complications.
Product: Arginine (ARG) ELISA Kit
Pub Date：2026-01-07 IF: 10.100
The bone marrow microenvironment is critical for the maintenance and functionality of stem/progenitor cells, which are essential for bone development and regeneration. However, the composition and potential use of bone marrow interstitial fluid have not been well explored.
Product: Bovine High mobility group protein B1 (HMGB1) ELISA Kit Bovine Lactoferrin (LTF) ELISA Kit
Pub Date：2025-12-15 IF: 15.000
The loss of phosphatase and tensin homolog (PTEN) can lead to resistance to immune checkpoint inhibitors (ICIs) in melanoma, thereby promoting immune evasion and tumor progression. These effects can be reversed by restoring PTEN expression, reactivating antitumor immunity, and enhancing therapeutic responses.
Product: Mouse High mobility group protein B1 (HMGB1) ELISA Kit
Pub Date：2025-12-11 IF: 11.500
Cutaneous wounds in male rats (Rattus norvegicus) are widely used as models for woundhealing research. C-reactive protein (CRP) is an inflammatory biomarker that increases in response to injury. Berastagi orange peel extract (Citrus sinensis L.) is known for its anti-inflammatory properties; however, its effectiveness in reducing serum CRP levels in cutaneous wounds has not been extensively studied.
Product: Rat C-Reactive Protein (CRP) ELISA Kit
Pub Date：2025-11-26 IF: 3.800
Crescentic glomerulonephritis (CrGN) with rapidly progressive renal function loss necessitates prompt pathology diagnosis and treatment. Non-invasive biomarkers are crucial in cases where renal biopsy is unavailable or unsuitable.
Product: Human Alcohol dehydrogenase 1C (ADH1C) ELISA Kit
Pub Date：2025-11-11 IF: 4.600
电话: 
邮箱: 
地址: